Increased access to contraception not linked to decrease in numbers of unplanned pregnancies, abortions

NewsGuard 100/100 Score

The belief that increased access to contraception will "reduce rates of unintended pregnancy and abortion" has "intuitive appeal, but the data prove otherwise," Susan Wills, associate director for education for the U.S. Conference of Catholic Bishops' Secretariat for Pro-Life Activities, writes in a Washington Post letter to the editor in response to a Post opinion piece by William Saletan, science and technology reporter for Slate magazine.

According to Wills, CDC data indicates that contraceptive use is "virtually universal among women of reproductive age."

The "problem" is that condoms and oral contraceptives "with typical use" have a 12-month pregnancy risk of 15% and 9%, respectively, Wills writes.

In addition, studies conducted in California, Washington state, Scotland, England, Sweden and China "show no reduction in pregnancy or abortion rates despite increased availability of contraception or emergency contraception," Wills concludes (Wills, Washington Post, 10/21).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New review aims to help clinicians diagnose and manage PCOS